Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Unresponsive Freezing of Gait after Deep Brain Stimulation in Parkinson's Disease

Parkinson's Disease
Belén González-HerreroMatilde Calopa

Abstract

Treatment of freezing of gait (FOG) is always challenging because of its unpredictable nature and multifactorial physiopathology. Intestinal levodopa infusion has been proposed in recent years as a valuable option for its improvement. FOG in Parkinson's disease (PD) can appear after deep brain stimulation in patients who never had gait symptoms. To study the effects of intestinal levodopa/carbidopa infusion in unresponsive-FOG that appears in PD patients treated with subthalamic nucleus deep brain stimulation. We retrospectively collected and analyzed demographic, clinical, and therapeutic data from five PD patients treated with subthalamic nucleus stimulation who developed unresponsive-FOG and received intestinal levodopa/carbidopa infusion as an alternative therapy. FOG was measured based on scores in item 14 of the Unified Parkinson's Disease Rating Scale before and after intestinal levodopa infusion. Administration of intestinal levodopa caused improvement of FOG in the "ON" state in four patients (80%) by 2 or more points in item 14 of the Unified Parkinson's Disease Rating Scale. The improvement was maintained for at least 12 months. Intestinal levodopa infusion may be a valuable therapeutic option for unresponsive-FOG de...Continue Reading

References

Mar 23, 2001·Journal of Neural Transmission·N GiladiA D Korczyn
Jul 19, 2001·Brain : a Journal of Neurology·M FaistC H Lücking
Jun 26, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J D SchaafsmaN Giladi
Jul 24, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·W HamelH M Mehdorn
Sep 17, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Jan HerzogJens Volkmann
Apr 21, 2007·Journal of the Neurological Sciences·Giorgio TommasiMichele Lanotte
Aug 1, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Yasuyuki Okuma, Nobuo Yanagisawa
Oct 28, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Bart F L van NuenenBastiaan R Bloem
Nov 16, 2014·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·Simon J G Lewis, James M Shine
Jan 13, 2015·Parkinsonism & Related Disorders·Florence C F ChangVictor S C Fung
May 6, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Giovanni CossuAngelo Antonini
May 29, 2015·Lancet Neurology·Jorik NonnekesBastiaan R Bloem
Sep 1, 2015·Neurophysiologie clinique = Clinical neurophysiology·A Collomb-Clerc, M-L Welter
Apr 30, 2017·Clinical Neuropharmacology·Ignacio RegidorJuan Carlos Martinez Castrillo
Dec 16, 2017·Movement Disorders Clinical Practice·David G StandaertJanet Benesh
Feb 7, 2018·Journal of the Neurological Sciences·Maurizio ZibettiLeonardo Lopiano
Dec 6, 2018·Movement Disorders Clinical Practice·Vittorio RispoliMariachiara Sensi
Apr 27, 2019·Acta Neurologica Scandinavica·Margherita FabbriLeonardo Lopiano
Nov 23, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Michael T BarbeUNKNOWN EARLYSTIM study group

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.